IMVT · Immunovant, Inc.

$39.05 -0.48 (-1.21%) At close · Jul 22

Market Cap

$8.02B

205.31M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2026

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Venker	CEO	$636,618	$503,345	—	$19,010,639	—	$8,165	$20,158,767
Peter Salzmann	CEO	$39,614	—	$8,287,949	$6,269,395	—	$737,642	$15,334,600
Michael Geffner	Chief Medical Officer	$345,521	—	$2,564,119	$2,145,870	—	$198,579	$5,254,089
Eva Renee Barnett	CFO	$26,250	—	$1,350,946	$1,462,825	—	$387,431	$3,227,452
Melanie Gloria	COO	$495,000	$245,025	$1,157,951	$1,150,095	—	$19,041	$3,067,112
Jay S. Stout	CTO	$495,000	$245,025	$1,157,951	$1,150,095	—	$17,650	$3,065,721
Christopher Van Tuyl	Chief Legal Officer and Corporate Secretary	$495,000	$245,025	$771,962	$766,726	—	$17,064	$2,295,777

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Salzmann	CEO	$724,500	$470,925	$4,941,237	$4,539,890	—	$55,575	$10,732,127
Christopher Van Tuyl	Chief Legal Officer and Corporate Secretary	$140,292	$62,860	$3,038,084	$2,699,742	—	$7,361	$5,948,339
Melanie Gloria	COO	$180,375	$79,465	$2,804,978	$2,500,844	—	$8,174	$5,573,836
Michael Geffner	Chief Medical Officer	$518,000	$233,100	$1,692,223	$1,554,789	—	$52,915	$4,051,027
Jay S. Stout	CTO	$481,000	$216,450	$1,692,223	$1,554,789	—	$34,891	$3,979,353
Eva Renee Barnett	CFO	$481,000	$216,450	$1,692,223	$1,554,789	—	$26,272	$3,970,734

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Salzmann	CEO	$700,000	$609,000	$3,584,330	$3,619,675	—	$39,425	$8,552,430
Jay S. Stout	CTO	$416,875	$241,932	$1,547,000	$1,809,390	—	$24,683	$4,039,880
Julia G. Butchko	Chief Development Officer	$465,000	$269,700	$1,472,764	$1,487,281	—	$12,966	$3,707,711
Eva Renee Barnett	CFO	$465,000	$269,700	$1,288,661	$1,301,372	—	$14,236	$3,338,969

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Salzmann	CEO	$625,000	$360,938	$2,251,807	$2,544,313	—	$37,760	$5,819,818
Eva Renee Barnett	CFO	$435,000	$414,430	$562,952	$636,078	—	$21,635	$2,070,095

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William L. Macias	Chief Medical Officer	$219,200	$94,630	$961,887	$1,142,334	—	$4,405,338	$6,823,389
Peter Salzmann	CEO	$600,000	$346,500	$3,999,997	$888,389	—	$33,455	$5,868,341
Eva Renee Barnett	CFO	$198,485	$328,027	$1,765,800	$2,126,272	—	$8,467	$4,427,051

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Salzmann	CEO	$567,000	$311,850	$3,252,500	$11,104,950	—	$139,004	$15,375,304

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael J. Elliott	M.B.B.S., Ph.D., FRACP Former Chief Scientific Officer	$242,425	$96,000	$1,659,200	$14,229,311	—	$9,695	$16,236,631
Rita Jain	Former Chief Medical Officer	$101,137	$38,526	$2,703,005	$10,666,997	—	$3,319	$13,512,984
Julia G. Butchko	Chief Development Officer	$372,000	$148,800	$926,500	$6,384,856	—	$10,201	$7,842,357
Pamela Yanchik Connealy	CFO	$393,000	$157,200	$785,400	$4,258,363	—	$8,742	$5,602,705

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Salzmann	CEO	$361,010	$500,000	—	$7,721,344	$224,480	—	$8,806,834
Pamela Yanchik Connealy	CFO	$147,618	—	—	$2,437,762	$61,233	$129,321	$2,775,934

Key facts CIK 1764013 CUSIP 45258J102 13F (30d) 16 filings 16 filers Visit website Investor relations